For $1,000, a small California-based company called 23andMe (financed in part by Google) will decode your DNA and tell you whatever it can about your predispositions, health risks, and family traits—for example, whether or not you’re in line for the same heart disease that affected your father and grandfather, which is what the author of the Wired article wondered. (Turns out he’s not, but he’s at a higher risk of developing glaucoma. When one door opens…)
medicine
Health Record Privacy Law Is Messing Up Research
By 11.14.07
Just days after a deputy director of national intelligence told Americans that we need to rethink our concepts of privacy, comes news that it may, in fact, be harming us in the long run. In a recent national survey, nearly 70% of research scientists said the 2003 Health Insurance Portability and Accountability Act (HIPAA) is “impeding scientific research, stalling clinical studies and halting others altogether.”
University of Pittsburgh Medical Center Cracks Down On Drug Reps
By 11.13.07
The University of Pittsburgh Medical Center is cracking down on drug reps, according to the Pittsburgh Post-Gazette. Details are still sketchy, but the general idea is that drug reps will no longer have direct access to doctors, but will instead drop off samples via a central office that will then distribute them to the staff.
Zyrtec Goes Behind-The-Counter
By 11.12.07
Zyrtec users can now buy it without a prescription—but they’ll have to show ID because it going to be sold from behind the counter with the other meth supplies. [Associated Press]
Zocor May Cause Sleep Problems In Patients
By 11.8.07
A new study from the University of California at San Diego School of Medicine suggests that simvastatin, also known as the cholesterol-lowering drug Zocor, may interfere with sleep patterns: “people who took the statin drug Zocor or simvastatin found they had significantly worse sleep quality compared with people who took Pravachol or pravastatin, another cholesterol-lowering drug.” Simvastatin is fat soluble, which means it can more easily penetrate cell membranes and mess with brain chemistry.
How To Pick A Good Doctor
By 11.8.07
“Most people spend more time picking out a can of beans than a new doctor,” says one expert in a Chicago Tribune article about how to find a properly licensed doctor that you’ll get along with. He and other experts recommend you arrange for a “first date” sort of interview, so you can ask general questions and get an overall feel for both the doctor and the practice, before the time comes when you need a doctor and don’t have the luxury of shopping around.
"Hide Your Old Pills In Poop"
By 11.7.07
The Reuters headline is so perfect, we can’t improve upon it. Hide your old pills in poop, folks, before you discard them, especially ones that are frequently abused like the painkillers oxycodone, morphine, and fentanyl, and the stimulant methylphenidate.
Can't Sleep? Try Behavioral Changes Before Sleeping Pills
By 11.7.07
The health blog at the New York Times points out that there are all sorts of behavioral changes you can adopt to fight insomnia that have been proven to work—they just sound so ordinary and common that people either don’t think they’re effective or assume pills will work better.
Red Bull Gives Your Blood Pressure Wings
By 11.7.07
People who have high blood pressure might want to avoid energy drinks, because a new study suggests that they might interfere directly with blood pressure or hamper the effectiveness of medications. The drinks, which have high levels of caffeine and taurine (“an amino acid found in protein-rich foods like meat and fish that can affect heart function and blood pressure”), raise blood pressure and heart rates in healthy individuals, but not to dangerous levels. However, for people who have cardiovascular disease or are taking heart rate or blood pressure medication, the increase could be “significant.”
Drug Reps Descend On Doctors Like A Plague Of Pen And Coffee Mug Bearing Locusts
By 11.6.07
Tomorrow, CNBC will be airing a story on the program Business Nation about the swarms of drug reps who buzz around your doctor’s office trying to convince her to give you Lipitor or Requip or whatever.
Fake Med Promoted Via Fraudulent Government Health & Drug Watchdog Site
By 11.6.07
The Chinese government has discovered a fake diabetes medicine on a fake research institute website, which then links to a fake version of the official government health and drug watchdog agency’s site. If you’re paying attention to urls, it’s hard to not notice that something’s wrong—but we’re sure there’s more than enough people who don’t notice that little detail.
Pfizer Launches Campaign To Warn Users Away From Generic Competitor
By 11.5.07
Pfizer is in panic mode about its rapid decline in Lipitor sales—in the last 18 months, it has dropped from 40% of the market for cholesterol-lowering drugs to 30%, and likely to drop further—so it’s launched a big media-blitz to convince people not to switch to simvastatin, the generic version of its name-brand competitor, Zocor. Zocor was more expensive than Lipitor, so Pfizer had nothing to worry about for years—but then Zocor lost its patent protection last year, and now doctors are switching patients from Lipitor over to Zocor’s generic twin to save money.
By 10.24.07
../../../..//2007/10/24/heres-a-frequently-updated/
Here’s a frequently updated list of the top 100 blogs focusing on health and medicine. The site uses rankings from Google, Bloglines, and Technorati, along with its own editorial ranking, to create the list, and it makes a good starting point if you want to fatten up your RSS reader with some…
Google Announces Plans For Online Personal Health Records Service
By 10.18.07
Microsoft beat them to the punch, but Google has announced that they, too, are planning to roll out a service that lets consumers store their medical records online and transfer them between health care providers as needed. Marissa Mayer at Google said the idea was spawned after reports of lost or damaged records in the wake of Hurricane Katrina: “It doesn’t make sense to generate this volume of information on paper. It should be something that is digital. People should have control over their own records.” Mayer says they hope to include things like x-rays, and that it “will take a lot of breakthroughs in digitization.”
Medtronic Stops Selling Faulty Defibrillators
By 10.15.07
Medtronic is “recalling” its latest heart defibrillator models because of faulty wiring, which could lead to either it not working when you most need it, or it shocking you randomly in the heart with painful electric jolts. “The company is urging all of the roughly 235,000 patients with the lead, known as the Sprint Fidelis, to see their doctors to make sure it has not developed a fracture that can make the device misread heart-rhythm data.”
FDA Might Create A "Behind-The-Counter" Drug Category
By 10.3.07
Next Month, the FDA will hold a public meeting to discuss whether or not they should allow certain drugs to be sold “behind-the-counter”—that is, after consultation with a pharmacist, but without the need for a prescription. If they move ahead with the plan, a new BTC category will be created, although what drugs will fall under it have not been determined.
Drug Company Fined MoreThan $500 Million For Inflating Drug Prices, Inappropriate Marketing
By 9.29.07
Given all the recent attention to industry money and off-label uses of atypical antipsychotics, we were particularly struck by the Abilify issue. The drug is approved only for bipolar disorder and schizophrenia in adults, but the Department of Justice accused the company of promoting its use for children and for elderly patients with dementia.
According to the Department of Justice, BMS created a special sales force specifically to target nursing homes. It’s unfortunate for those patients that the drug carries a warning of increased death among elderly patients with dementia-related psychosis who are treated with atypical antipsychotics.
How To Fill A 120-Day Prescription For 1/5th Of The Regular Price
By 9.26.07
Here’s a potential way to get certain drug prescriptions filled cheaply—as in, a several-month supply for less than $15—from our own Consumerist reader and commenter Hambriq. He posted it last week and we thought it was worth bringing to the foreground for more readers to see.
